Evidence map›Paper›PMID 36427880›Full record

Observational studyClinical medicine (London, England)2022

NEWS2 shows low sensitivity and high specificity for delirium detection: a single site observational study of 13,908 patients.

Emma Rlc Vardy, Schanhave Santhirasekaran, Michael Cheng, Atul Anand, Alasdair M MacLullich

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Clinical medicine (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Observational
  3. NEWS2 and the older person.Clinical medicine (London, England) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Emma Rlc VardyNorthern Care Alliance NHS Foundation Trust, Salford, UK and School of Health Sciences and NIHR Applied Research Collaboration Greater Manchester, Manchester, UK emma.vardy@nca.nhs.uk.
Schanhave SanthirasekaranNorthern Care Alliance NHS Foundation Trust, Salford, UK.
Michael ChengMersey Care NHS Foundation Trust, Prescot, UK.
Atul AnandCentre for Cardiovascular Science, Edinburgh, UK and honorary consultant in geriatric medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
Alasdair M MacLullichUsher Institute, Edinburgh, UK and Royal Infirmary of Edinburgh, Edinburgh, UK.
Mersey Care NHS Trust · GBNorthern Health and Social Care Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delirium affects 25% of hospital admissions of older people and is a serious medical condition with poor outcomes. 'New confusion' as a delirium indicator was incorporated into the 'alert, verbal, pain and unresponsive' (AVPU) level of consciousness scale in the National Early Warning Score 2 (NEWS2) in 2017. We measured sensitivity of non-alert NEWS2 (new confusion and/or V, P or U ratings) for delirium through comparison with the four 'A's test (4AT) delirium tool in 13,908 consecutive non-elective hospital admissions. We included NEWS2 scores 4 hours before or after 4AT. There were 2,802 (20%) admissions with positive 4AT and 594 (4.3%) with non-alert NEWS2 status. Sensitivity of NEWS2 for 4AT ≥4 was 17.8% (95% confidence interval (CI) 16.4-19.2), and specificity was 99.1% (95% CI 98.9-99.3). These findings suggest that NEWS2 in current practice has low sensitivity but high specificity for delirium. Further research is needed to improve routine inpatient monitoring for delirium.

Indexed as

DeliriumAgedHospitalizationHumansInpatients4ATalertnessdeliriumdetectionNEWS2

Identifiers

PMID36427880
PMCPMC9761437
OpenAlexW4310299223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.